Edition:
United States

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

143.81USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$143.81
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
483,713
52-wk High
$202.18
52-wk Low
$114.54

Latest Key Developments (Source: Significant Developments)

McKesson Corporation signs definitive agreements to purchase Vantage Oncology, LLC
Thursday, 25 Feb 2016 08:30am EST 

McKesson Corporation:signed definitive agreements to purchase Vantage Oncology, LLC, a leading national provider of radiation oncology, medical oncology and integrated cancer care, and Biologics, Inc., an oncology pharmacy services company.The combined transactions, valued at $1.2 billion, will be funded by a mix of cash and incremental debt and are expected to close in the first quarter of Fiscal 2017, subject to customary closing conditions, including necessary regulatory clearances.Following the close of the transactions, both Vantage and Biologics will become part of McKesson's Specialty Health business.McKesson expects the combined impact of these transactions to be approximately 11 cents accretive to adjusted earnings per diluted share in Fiscal 2017.  Full Article

McKesson Corp reaffirms FY 2016 and FY 2017 EPS outlook
Wednesday, 27 Jan 2016 04:10pm EST 

McKesson Corp:Outlook for FY 2016 and FY 2017 remains the same as what company provided on January 11, 2016.Expects Adjusted Earnings per diluted share between $12.60 and $12.90 for FY 2016.Expects growth in Adjusted Earnings per diluted share for FY 2017 to be between 3% and 8%, as reported, and between 7% and 12%, excluding 48 cents of gains on disposition of two businesses and favorable discrete tax items in FY 2016.  Full Article

McKesson declares regular dividend
Wednesday, 27 Jan 2016 04:00pm EST 

McKesson Corp:Declared a regular dividend of twenty-eight cents per share on Common Stock.Payable on April 1, 2016, to stockholders of record on March 1, 2016.  Full Article

McKesson Corp revises FY 2016 EPS outlook; gives FY 2017 EPS outlook
Monday, 11 Jan 2016 08:30am EST 

McKesson Corp:Announced update to its outlook for adjusted earnings per diluted share for FY 2016, from the previous range of $12.50 to $13.00 to a new range of $12.60 to $12.90.Says updated outlook for FY 2016 reflects McKesson's expectation that operating profit derived as a result of generic pharmaceutical pricing trends will be weaker in the second half of the fiscal year compared to previous expectations.Says that it has preliminary target of 7% to 12% growth in adjusted earnings per diluted share for FY 2017.  Full Article

McKesson Corp raises FY 2016 EPS guidance
Thursday, 29 Oct 2015 07:30am EDT 

McKesson Corp:Now Expects FY 2016 Adjusted Earnings per diluted share of $12.50 to $13.00.FY 2016 EPS of $12.69 - Thomson Reuters I/B/E/S.  Full Article

McKesson announces agreement to purchase the pharmaceutical distribution division of UDG Healthcare
Friday, 18 Sep 2015 05:00am EDT 

McKesson Corporation:Announces an agreement to purchase the pharmaceutical distribution division of UDG Healthcare (UDG) based in Northern Ireland (United Drug Sangers) and the Republic of Ireland (United Drug).Says under the terms of the agreement mckesson will acquire: United Drug and United Drug Sangers, wholesale operations across the Republic of Ireland and Northern Ireland; TCP, and MASTA, UDG's travel healthcare business based in the United Kingdom.  Full Article

McKesson Corp to expand distribution agreement with Albertsons
Tuesday, 15 Sep 2015 04:10pm EDT 

McKesson Corp:Mckesson to expand distribution agreement with albertsons.Says distribution agreement extends through April 2021.Says Mckesson to assume responsibility for the sourcing and distribution of generic and brand pharmaceuticals.Albertsons' network will benefit from the scale and strength of mckesson's proprietary onestop (reg) generics program.Five-year distribution agreement to include sourcing and distribution of branded and generic pharmaceuticals, commencing on April 1, 2016.  Full Article

Cintas Corporation announces agreement to purchase ZEE Medical from McKesson Corp
Friday, 31 Jul 2015 09:00am EDT 

Cintas Corporation:Announces that it has entered into a definitive agreement to purchase ZEE Medical from McKesson Corporation for consideration of about $130 million in cash.Says the transaction is expected to close on Aug. 1.  Full Article

McKesson declares regular dividend
Wednesday, 29 Jul 2015 04:20pm EDT 

McKesson Corp:Declares a regular dividend of $0.28 per share on Common Stock, a $0.04 increase from the prior quarter.Payable on Oct. 1, to stockholders of record on Sept. 1.  Full Article

McKesson Corp raises FY 2016 EPS guidance
Wednesday, 29 Jul 2015 04:10pm EDT 

McKesson Corp:Expects adjusted earnings per diluted share of $12.36 to $12.86 for FY 2016.FY 2016 EPS of $12.59 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Celesio H1 adj EBIT down at 157.1 million euro

* EBIT (earnings before interest and taxes) for continuing operations saw a decrease of 36.0 per cent to 146.3 million euro ($155.77 million) in first half of fiscal 2017